These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12801218)

  • 1. 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.
    Linhardt RJ
    J Med Chem; 2003 Jun; 46(13):2551-64. PubMed ID: 12801218
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Heparin'--from anticoagulant drug into the new biology.
    Lindahl U
    Glycoconj J; 2000; 17(7-9):597-605. PubMed ID: 11421351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic heparin and heparan sulfate: probes in defining biological functions.
    Tsai CT; Zulueta MML; Hung SC
    Curr Opin Chem Biol; 2017 Oct; 40():152-159. PubMed ID: 29032302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assays and reference materials for current and future applications of heparins.
    Mulloy B; Hogwood J; Gray E
    Biologicals; 2010 Jul; 38(4):459-66. PubMed ID: 20338781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of the molecular diversity of heparin and heparan sulfate for drug development.
    Fügedi P
    Mini Rev Med Chem; 2003 Nov; 3(7):659-67. PubMed ID: 14529507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and biological interactions of heparin and heparan sulfate.
    Casu B; Lindahl U
    Adv Carbohydr Chem Biochem; 2001; 57():159-206. PubMed ID: 11836942
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of biologically active heparan sulfate and heparin using an enzyme-based approach.
    Peterson S; Frick A; Liu J
    Nat Prod Rep; 2009 May; 26(5):610-27. PubMed ID: 19387498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity.
    Andrade GP; Lima MA; de Souza Junior AA; Fareed J; Hoppensteadt DA; Santos EA; Chavante SF; Oliveira FW; Rocha HA; Nader HB
    Carbohydr Polym; 2013 Apr; 94(1):647-54. PubMed ID: 23544586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of heparin revisited: the peptone connection.
    Marcum JA
    Perspect Biol Med; 1996; 39(4):610-25. PubMed ID: 8753764
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica.
    Liu J; Zhou L; He Z; Gao N; Shang F; Xu J; Li Z; Yang Z; Wu M; Zhao J
    Carbohydr Polym; 2018 Feb; 181():433-441. PubMed ID: 29253994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
    Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
    Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. J. Erik Jorpes--pioneer in the identification and clinical applications of heparin.
    Shampo MA; Kyle RA
    Mayo Clin Proc; 1997 Nov; 72(11):1056. PubMed ID: 9374981
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyphenated techniques for the analysis of heparin and heparan sulfate.
    Yang B; Solakyildirim K; Chang Y; Linhardt RJ
    Anal Bioanal Chem; 2011 Jan; 399(2):541-57. PubMed ID: 20853165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin sulfate fractions on coagulation and hemostasis.
    Nader HB; Dietrich CP
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):504-8. PubMed ID: 4275736
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin--an introduction.
    Rodén L; Ananth S; Campbell P; Curenton T; Ekborg G; Manzella S; Pillion D; Meezan E
    Adv Exp Med Biol; 1992; 313():1-20. PubMed ID: 1442253
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin and heparan sulfate: biosynthesis, structure and function.
    Sasisekharan R; Venkataraman G
    Curr Opin Chem Biol; 2000 Dec; 4(6):626-31. PubMed ID: 11102866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.
    Kleiman NS; Weitz JI
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():20F-6. PubMed ID: 11156730
    [No Abstract]   [Full Text] [Related]  

  • 18. Vijay Kakkar.
    BMJ; 2017 Jan; 356():i6852. PubMed ID: 28049166
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological properties of synthetic glycoconjugate mimics of heparin comprising different molecular spacers.
    Dreef-Tromp CM; Basten JE; Broekhoven MA; van Dinther TG; Petitou M; van Boeckel CA
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2081-6. PubMed ID: 9873490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity.
    Lopalco L; Ciccomascolo F; Lanza P; Zoppetti G; Caramazza I; Leoni F; Beretta A; Siccardi AG
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):787-93. PubMed ID: 7986584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.